| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |